Pharmacokinetics of Darunavir (TMC114) and Atazanavir during Coadministration in HIV-Negative, Healthy Volunteers

MLA

Sabrina Spinosa-Guzman, et al. “Pharmacokinetics of Darunavir (TMC114) and Atazanavir during Coadministration in HIV-Negative, Healthy Volunteers.” Drugs in R & D, vol. 8, Jan. 2007, pp. 241–48. EBSCOhost, https://doi.org/10.2165/00126839-200708040-00004.

APA

Sabrina Spinosa-Guzman, Els De Paepe, Tony Vangeneugden, Vanitha Sekar, Richard M. W. Hoetelmans, Eric Lefebvre, Tine De Marez, & Martine De Pauw. (2007). Pharmacokinetics of Darunavir (TMC114) and Atazanavir during Coadministration in HIV-Negative, Healthy Volunteers. Drugs in R & D, 8, 241–248. https://doi.org/10.2165/00126839-200708040-00004

Chicago

Sabrina Spinosa-Guzman, Els De Paepe, Tony Vangeneugden, Vanitha Sekar, Richard M. W. Hoetelmans, Eric Lefebvre, Tine De Marez, and Martine De Pauw. 2007. “Pharmacokinetics of Darunavir (TMC114) and Atazanavir during Coadministration in HIV-Negative, Healthy Volunteers.” Drugs in R & D 8 (January): 241–48. doi:10.2165/00126839-200708040-00004.